Riskpilot← Back to searchSign inGet full accessNORDMEDICA A/S
A/SActiveCVR 27299032Skovvej 93Wholesale of pharmaceutical and medical goods · NACE 4646Est. 2003— employeeswww.nordmedica.com
Revenue 2025
DKK -26K
-117% vs 2024
EBITDA margin
100.0%
-117% vs 2024
Equity ratio
89.8%
Financial strength
Net profit 2025
DKK -20K
-103% vs 2024
| Revenue | DKK -26K | -117% |
| EBITDA | DKK -26K | -117% |
| Net profit | DKK -20K | -103% |
| Total assets | DKK 977K | -2% |
| Equity | DKK 877K | -2% |
| Employees | — | — |
Legal name
NORDMEDICA A/S
CVR number
27299032
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. juli 2003
Share capital
DKK 555.556
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse eller af to medlemmer af bestyrelsen i forening eller af en direktør.
Company purpose
Selskabets formål er at drive handels-, rådgivnings- og konsulentvirksomhed inden for den farmaceutiske industri.
Address
Skovvej 93
Email
info@nordmedica.com
Website
www.nordmedica.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1.002 | 635 | 588 | 153 | -26 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 1.002 | 635 | 588 | 153 | -26 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 1.002 | 635 | 588 | 153 | -26 |
| Net financials | 27 | 331 | 460 | 648 | 8 |
| Profit before tax | 1.029 | 965 | 1.047 | 801 | -18 |
| Tax | 244 | 242 | 281 | 185 | 2 |
| Net profit | 785 | 723 | 766 | 616 | -20 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 12.202 | 13.103 | 13.871 | 998 | 977 |
| Equity | 11.845 | 12.549 | 13.283 | 897 | 877 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 333 | 520 | 588 | 101 | 99 |
| Total debt | 333 | 520 | 588 | 101 | 99 |
EBITDA margin
-2598900.0%
This company
15.8%
Market median
-16448834% vs market
20212025
Equity ratio
89.8%
This company
38.2%
Market median
+135% vs market
20212025
Return on equity
-2.3%
This company
18.4%
Market median
-113% vs market
20212025
Net profit margin
-2028900.0%
This company
8.1%
Market median
-25048248% vs market
20212025
Asset turnover
-0.03×
This company
1.12×
Market median
-103% vs market
20212025
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
Mv Chief Executive Officer | Chief Executive Officer | 2013 |
| Former (4) | ||
KB Audit | Audit | 2003 – 2003 |
VC Chief Executive Officer | Chief Executive Officer | 2003 – 2003 |
SA Management | Management | 2003 – 2005 |
BB Chief Executive Officer | Chief Executive Officer | 2003 – 2013 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2017 | |
| Board of Directors | 2022 | |
| Former (4) | ||
| Board of Directors | 2009 – 2013 | |
| Chairman | 2009 – 2013 | |
| Chairman | 2013 – 2017 | |
| Board of Directors | 2013 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2013 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NORDMEDICA A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl-Alfred Brylle | Audit | 0 companies |
| Victor Christoffersen | Chief Executive Officer | 0 companies |
| Svend Aage Johansen | Management | 0 companies |
| Bent Benny Andersen | Chief Executive Officer | 0 companies |
| Michael van Woensel | Chief Executive Officer | 0 companies |
| Thomas Willem Johannes Nicolaas Calis | Chairman | 0 companies |
| Mads Christian Olesen | Board of Directors | 0 companies |
| Birgitte Stenbjerre | Chairman | 0 companies |
| Anna Novikova | Board of Directors | 0 companies |
| Willem Frans van Doorn | Chairman | 0 companies |
| Anthony Louis Julius Theodoor Joseph Amoureus | Board of Directors | 0 companies |